Send the following on WhatsApp
Continue to Chat雲頂新耀宣佈合作夥伴Calliditas Therapeutics的NEFECON在歐盟以商品名Kinpeygo®獲批,用於治療原發性IgA腎病成人患者 https://geneonline.news/%e9%9b%b2%e9%a0%82%e6%96%b0%e8%80%80%e5%ae%a3%e4%bd%88%e5%90%88%e4%bd%9c%e5%a4%a5%e4%bc%b4calliditas-therapeutics%e7%9a%84nefecon%e5%9c%a8%e6%ad%90%e7%9b%9f%e4%bb%a5%e5%95%86%e5%93%81%e5%90%8dkinpeygo/